Thursday Feb 9 | Wall St. Cheat Sheet
Jim Cramer Stock Watch: Feb 8th Stock Picks
Bristol-Myers Squibb Company : Jim Cramer ranked this stock a Buy . The stock closed at $32.08, its 52-week high is $35.44, and its 52-week low is $24.97. Buffalo Wild Wings Inc.
Thursday Feb 9 | Wall St. Cheat Sheet
Becton Dickinson and Steris Corporation Give Glimpse into Healthcare Earnings
Becton Dickinson and Company A reported its results for the first quarter.A Net income for the medical instruments and supplies company fell to $263 million vs.
Thursday Feb 9 | Freshnews
Covidien to Present at Leerink Swann Conference
Covidien , a leading global provider of healthcare products, will present at the Leerink Swann 2012 Global Healthcare Conference in New York, New York, on February 16, 2012.
Earnings Preview Watch: Becton, Dickinson and Co. and Cerner Corp. on Deck
Becton, Dickinson and Co. will unveil its latest earnings on Tuesday, February 7, 2012.A The average estimate of analysts is for profit of $1.17 per share, a decline of 13.3% from the company's actual earnings for the same quarter a year ago.
Results from Solitaire with the Intention for Thrombectomy (SWIFT)...
Results from the Solitaire with the Intention for Thrombectomy Study will be announced at a press conference at 8AM CT - followed by a late breaking trial presentation at 12 PM CT.
Hercules to gain $2M from selling Barrx Medical
Earlier this month, Hercules completed the sale of all its outstanding shares of Sunnyvale-based Barrx to Covidien plc in a deal valued at $325 million.
Study: How Biomedical Devices Industry Hurdled Economic Downturn
A new analysis from the global tax and business advisory firm WTP Advisors has identified three specific business practices that led to industry success.
Covidien device joins stroke treatment trial
The Solitaire FR Revascularization Device by Covidien plc won approval for investigational use in the thromectomy part of the Interventional Management of Stroke trial, funded by the National Institute of Neurological Disorders and Stroke.
Covidien plc (COV) Shares Given New $60.00 Price Target by Citigroup (C) Analysts
Investment analysts at Citigroup upped their price target on shares of Covidien plc to $60.00 in a note issued to investors on Friday.
Covidien Reports First-Quarter Results
Covidien plc today reported results for the first quarter of fiscal 2012 . First-quarter net sales of $2.90 billion increased 5% from the $2.77 billion reported a year ago.
2 Stocks Trading Slightly Lower Ahead of Earnings Reports
Covidien Ltd. will unveil its latest earnings on Thursday, January 26, 2012.A The average estimate of analysts is for net income of $1.03 per share, a rise of 8.4% from the company's actual earnings for the same quarter a year ago.
Clinical Data for Durability II Study Presented at Iset 2012
Covidien , a leading global provider of healthcare products, today announced that one-year results on the use of its EverFlex stent for superficial femoral artery stenting were presented here during the International Symposium on Endovascular Therapy Conference.
Covidien Ltd. First Quarter Earnings Sneak Peek
Covidien Ltd. will unveil its latest earnings on Thursday, January 26, 2012. Covidien is engaged in the development, manufacture, and sale of healthcare products for use in clinical and home settings.
Covidien Appoints New Leader for Vascular Therapies Business
Covidien , a leading global supplier of healthcare products, today announced that Stacy Enxing Seng has been appointed President of the Company's Vascular Therapies Global Business Unit.
Covidien board names CEO to added post as chairman
Almeida, 49, became president, CEO and a member of the Dublin company's board in July, when former president and CEO Richard J. Meelia retired.
US Food and Drug Administration
Covidien Contraindicates the Use of Duet TRS for Thoracic Surgery, Implements a Voluntary Recall
Contact: Customer Service 1-800-722-8772 FOR IMMEDIATE RELEASE - January 16, 2012 -Covidien , a leading global provider of healthcare products, today announced that it is conducting a voluntary recall of all production lots for the Duet TRS Universal Straight and Articulating Single Use Loading Units, with respect to the use of this product family ... (more)
Deaths prompt Covidien to recall stapler, halt use in chest surgery
Medical devices company Covidien plc has issued a voluntary recall for all of its Duet TRS single-use stapling heads, and said they shouldn't be used in their approved indication, thoracic surgery, after reports of 13 injuries and three deaths.
ORLive Program Highlights Revolutionary Technology for Plastic Surgeries
On Wednesday, January 18th, Covidien Surgical Devices is hosting an interactive discussion with plastic surgeons about their experiences using the V-LocA wound closure device in plastic reconstructive surgery -- live from Elancourt, France.